Oncolytic adenovirus, a new treatment strategy for prostate cancer

HIGHLIGHTS

• who: Kaiyi Yang and collaborators from the Department of Urology, Xiangya Hospital, Central South University, Changsha, China have published the Article: Oncolytic Adenovirus, a New Treatment Strategy for Prostate Cancer, in the Journal: Biomedicines 2022, 10, 3262. of 15/Dec/2022
• what: The aim of this study is to evaluate the safety and effectiveness of AD5SGE-REIC/Dkk-3 in patients with localized prostate cancer.
• how: The results showed that 94% of patients had mild to moderate adverse reactions but all had different degrees of remission 44% (7/16) of patients had serum . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.